Vincenza I. Bartl
The Agent That Works Harder After The Closing Papers Are Signed.
Tuesday, July 18, 2017
Big Pharma Share Buybacks Not Impacting R&D Budgets
But to imply that share buybacks reduce the amount of money allotted to R&D is not correct.
from Forbes Real Time http://www.forbes.com/sites/johnlamattina/2017/07/18/big-pharma-share-buybacks-not-impacting-rd-budgets/
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment